申请人:INSTITUT NATIONAL DE LA SANTE ET
DE LA RECHERCHE MEDICALE (INSERM)
公开号:EP3412651A1
公开(公告)日:2018-12-12
The present invention concerns a compound having the following formula (I): wherein:
- A is in particular -N(R'a)-C(=O)-R, R'a being H or a (C1-C6)alkyl group, and R being preferably a group having the following formula (II):
- X is in particular chosen from the group consisting of: -SO2-N(R'b)-, R'b being H or a (C1-C6)alkyl group, -N(R"b)-SO2-, R"b being H or a (C1-C6)alkyl group, -CO-NH-, and -NH-CO-,
for use for the treatment of pathologies characterized by bronchoconstriction, such as asthma.
本发明涉及具有以下式(I)的化合物:其中:- A特别是-N(R'a)-C(=O)-R,其中R'a为H或(C1-C6)烷基基团,R优选为具有以下式(II)的基团:- X特别是从以下组中选择的:-SO2-N(R'b)-,其中R'b为H或(C1-C6)烷基基团,-N(R"b)-SO2-,其中R"b为H或(C1-C6)烷基基团,-CO-NH-和-NH-CO-,用于治疗以支气管痉挛为特征的病理,如哮喘。